For normal-weight women, the intervention had a weak positive effect on glucose metabolism, as evidenced by a trend (p < 0.1) toward reduced insulin and insulin-resistance and significantly lower leptin values, although there was no change in mean glucose levels or the proportion exceeding thresholds for GDM diagnosis. This evidence concerns the gene LEP and Insulin resistance.